Relation between voice handicap index (VHI) and disease severity in iranian patients with parkinson's disease

Medical Journal of the Islamic Republic of Iran

Volumn 26, Issue 4, 2012, Pages 157-163

  Majdinasab, Fatemeh ^a   Karkheiran, Siamak ^b   Moradi, Negin ^a   Shahidi, Gholam Ali ^b   Salehi, Masoud ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Disease severity; Parkinson's disease; Quality of life; VHI; Voice

Indexed keywords

EID: 84872564555     PISSN: 10161430     EISSN: 22516840     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Khoo TK, Burn DJ. Non-motor symptoms may herald Parkinson's disease. Practitioner2009 Sep; 253(1721):19-24,2
2. Fahn S, Jankovic J. principles and practice of movement disorders. Philadelphia: Churchill Livingstone Elsevier; 2007.pp. 212-22.
3. Goberman AM. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease. Med Sci Monit2005 Mar; 11(3):CR109-16.
4. Goberman AM, Blomgren M. Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease. J Voice 2008 Mar;22(2):178-91.
5. Chen JJ. Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care 2010 Mar; 16 Suppl Implications:S87-93.
6. Harel BT, Cannizzaro MS, Cohen H, Reilly N, Snyder PJ. Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment. Journal of Neurolinguistics 2004; 17(6):439-53.
7. Skodda S, Visser W, Schlegel U. Vowel Articulation in Parkinson's Disease. Journal of Voice2010; 25(4):467-72.
8. Mate MA, Cobeta I, Jimenez-Jimenez FJ, Figueiras R. Digital Voice Analysis in Patients With Advanced Parkinson's Disease Undergoing Deep Brain Stimulation Therapy. J Voice Jun 24.
9. Zarzur AP, Duarte IS, Goncalves Gdo N, Martins MA. Laryngeal electromyography and acoustic voice analysis in Parkinson's disease: a comparative study. Braz J Otorhinolaryngol2010 Feb; 76(1):40-3.
10. Logemann JA, Fisher HB, Boshes B, Blonsky ER. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord1978 Feb; 43(1):47-57.
11. Zwirner P, Barnes GJ. Vocal tract steadiness: a measure of phonatory and upper airway motor control during phonation in dysarthria. J Speech Hear Res1992 Aug; 35(4):761-8.
12. Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol1998; 11(3):131-7.
13. Sewall GK, Jiang J, Ford CN. Clinical evaluation of Parkinson's- related dysphonia. Laryngoscope2006 Oct; 116(10):1740-4.
14. Hakkesteegt MM, Brocaar MP, Wieringa MH. The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery. J Voice 2009 Mar; 24(2):199-205.
15. Schindler A, Ottaviani F, Mozzanica F, Bachmann C, Favero E, Schettino I, et al.. Crosscultural adaptation and validation of the Voice Handicap Index into Italian. J Voice 2010 Nov; 24(6):708- 14.
16. Behlau M, Alves Dos Santos Lde M, Oliveira G. Cross-cultural adaptation and validation of the voice handicap index into Brazilian Portuguese. J Voice2011 May; 25(3):354-9.
17. Gamboa J, Jimenez-Jimenez FJ, Mate MA, Cobeta I. [Voice disorders caused by neurological diseases]. Rev Neurol 2001 Jul 16-31; 33(2):153-68.
18. Helidoni ME, Murry T, Moschandreas J, Lionis C, Printza A, Velegrakis GA. Cross-cultural adaptation and validation of the voice handicap index into Greek. J Voice 2010 Mar; 24(2):221-7.
19. Maertens K, de Jong FI. The voice handicap index as a tool for assessment of the biopsychosocial impact of voice problems. B-ENT 2007; 3(2):61-6.
20. Zhao YJ, Wee HL, Chan YH, Seah SH, Au WL, Lau PN, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times. Mov Disord 2010 Apr 30; 25(6):710-6.
21. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 2005 Nov 8; 65(9):1436-41.
22. Muller T, Harati A. Diadochokinetic movements differ between patients with Parkinson's disease and controls. J Neural Transm 2010 Feb; 117(2):189-95.
23. Colton RH, Casper JK, Leonard R. understanding voice problems: a physiological perspective for diagnosis and treatment. 3rd ed. philadelphia: lippincott Williams and Wilkins; 2006.
24. Ghadirzadeh M, Fadaievatan R, Akbarikamrani A, Davatgaran K, Hasheminazari S, Mirtorabi D. Road Accident Mortality of the Iranian Elderly from 2006 to 2008. Salmand (Iranian Journal of Aging) 2012; 7(23).
25. Frost E, Tripoliti E, Hariz MI, Pring T, Limousin P. Self-perception of speech changes in patients with Parkinson's disease following deep brain stimulation of the subthalamic nucleus. Int J Speech Lang Pathol Oct; 12(5):399-404.
26. Bauer V, Aleric Z, Jancic E, Miholovic V. Voice quality in Parkinson's disease in the Croatian language speakers. Coll Antropol2011 2012; 35 Suppl 2:209-12.
27. Spielman J, Ramig LO, Mahler L, Halpern A, Gavin WJ. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease. Am J Speech Lang Pathol2007 May; 16(2):95-107.
28. Midi I, Dogan M, Koseoglu M, Can G, Sehitoglu MA, Gunal DI. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease. Acta Neurol Scand2008 Jan; 117(1):26-34.
29. Accolla E, Caputo E, Cogiamanian F, Tamma F, Mrakic-Sposta S, Marceglia S, et al.. Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation. Mov Disord2007 Jun 15; 22(8):1150-6.
30. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 2009 Nov 3; 73(18):1469-77.
31. Bayes-Rusinol A, Forjaz MJ, Ayala A, Crespo Mde L, Prats A, Valles E, et al. [Awareness of dysphagia in Parkinson's disease]. Rev Neurol 2011 Dec 1; 53(11):664-72.
32. Goberman AM, Coelho C. Acoustic analysis of parkinsonian speech I: speech characteristics and LDopa therapy. NeuroRehabilitation2002;17(3):237- 46.
33. Gamboa J, Jiménez-Jiménez FJ, Nieto A, Montojo J, Ort-Pareja M, Molina JA, et al. Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs. Journal of Voice 1997; 11(3):314-20.
34. Jimenez-Jimenez FJ, Gamboa J, Nieto A, Guerrero J, Orti-Pareja M, Molina JA, et al. Acoustic voice analysis in untreated patients with Parkinson's disease. Parkinsonism Relat Disord 1997 Apr; 3(2):111-6.
35. Hertrich I, Ackermann H. Gender-specific vocal dysfunctions in Parkinson's disease: electroglottographic and acoustic analyses. Ann Otol Rhinol Laryngol 1995 Mar; 104(3):197-202.
36. Skodda S, Visser W, Schlegel U. Gender- Related Patterns of Dysprosody in Parkinson Disease and Correlation between Speech Variables and Motor Symptoms. J Voice 2009 Apr 8.
37. Skodda S, Rinsche H, Schlegel U. Progression of dysprosody in Parkinson's disease over time--a longitudinal study. Mov Disord 2009; 24(5):716-22.
38. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002;17 Supp l3: S94-101.
39. Krischke S, Weigelt S, Hoppe U, Kollner V, Klotz M, Eysholdt U, et al. Quality of life in dysphonic patients. J Voice 2005 Mar; 19(1):132-7.
40. Moradi N, Soltani M, Javadipoor S, Poorshahbaz A, Hashemi H, Soltani N. Cross- Cultural Adaptation and Validation of the Voice Handicap Index into Iranian 10th Iranian congress of Speech Therapy; Ahvaz: Ahvaz Jundishapur University of Medical sciences 2011; p14.
41. Madjdinasab F, Jalilevand N, Shahidi G, Moradi N, Karkheiran S, salehi M. Relation between oral diadochokinesis and disease severity in Iranian patients with idiopathic Parkinson's disease Iranian Journal of War and Public Health 2011.